Share this
Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion
August 5, 2021
ArTara Agrees to Combine With Proteon
Transaction to create Nasdaq-listed rare and specialty disease therapeutic company • September 27, 2019
Mirum Pharmaceuticals Closes $120 Million Series A
Company also acquires rights to rare liver disease program from Shire • November 21, 2018
TRACON – $17 Million Shelf-Takedown
December 6, 2016
Flexion – $70 Million Shelf-Takedown
November 29, 2016
Flexion – $77 Million Follow-On Offering
July 7, 2016
TRACON Pharmaceuticals Completes Initial Public Offering
February 13, 2015
Cooley Advises Eagle on Initial Public Offering
February 26, 2014
Cooley Advises Flexion on Initial Public Offering
Cooley Advises Auspex on its Initial Public Offering
February 24, 2014
Cooley Advises Xencor on its Initial Public Offering
December 10, 2013
Cooley Advises Ambit on its Initial Public Offering
May 21, 2013
Cooley Advises Underwriters on Receptos, Inc. Initial Public Offering
May 20, 2013
Cooley Advises Insys Therapeutics on its IPO
May 9, 2013
Cooley Advises Hot Topic in its $600 Million Sale to Sycamore Partners
March 7, 2013